By utilizing a specialized database, this study is ensuring the utmost safety and efficacy of the medication.

Monday morning pre-market screamer 😱 candidates: 🚨🚨🚨💎💎💎🔥🔥🔥 $TCBP Phase 2 update still pending-huge potential on this nano float $BOXD over $1 easy $ALLR PT $.50 $HTGM she’s ready for another big run This week was very good to me.

$BOXD now entering parabolic phase 🪐🚀🪐

By utilizing a specialized database, this study is ensuring the utmost safety and efficacy of the medication.

$NRBO check out all of the trials they have going on and backed by DONG A-ST this is the making of a MEGA RUNNER.

Successful phase 2 which will be final approved April 2023 .

3.67 cash per share and $20+ PT's. Not to mention, consistency with positive studies and data.

Phase 3 results were solid.

$BXRX must be good phase 2 data

I can only imagine how useful it will be clinical setting, much like a Toradol Injection is used.

$SNAP $META $GOOGL $PINS gonna go up $BXRX is just getting started imo huge phase 2 trial and great fundamentals

$AFRM $UPST $SOFI $DLO good fintech companies $BXRX holy shiiii amazing news with starting their trials and great fundamentals

Monday morning pre-market screamer 😱 candidates: 🚨🚨🚨💎💎💎🔥🔥🔥 $TCBP Phase 2 update still pending-huge potential on this nano float $BOXD over $1 easy $ALLR PT $.50 $HTGM she’s ready for another big run This week was very good to me.

SIMILAR SETUP TO $AMAM, $HTGM, $APVO, $APCX Volume increasing since last week ✅ Low float recent IPO ✅ Strong future trial pipeline ✅ Time for the next leg up towards IPO price!

SHOULD be some awesome opportunities this week, study study study!

$ATNM positive news in their acute myeloid leukemia trials 👇🏼 53% 1-year Overall Survival and 32% 2-year Overall Survival are approximately double outcomes with current approaches It's time to get in before we blast off to $12+ next!